Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Our Work
With UCSF Researchers
With Campus Partners
With Affiliates
With Community Partners
With State Partners
With National Partners
With Consortia Partners
Programs
Bioethics & Regulatory Engagement
Biospecimen Processing Lab
Clinical Research Services
Clinical & Translational Science Training
Clinical Trials Operations
Community Engagement
Consultation Services
IMPACT
Informatics & Research Innovation
Participant Recruitment
Pilot Awards
RAGE
Research Infrastructure Network
Research Technology
Team Science
Trial Innovation Network
News & Media
About Us
About Us
Team
CTSI Celebrates
CTSI Open House
Careers
Letters of Support
NIH Funding Acknowledgment
Contact
You are here
Home
>
Cancer research
Cancer research
Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers.
Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.
Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.
Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.
p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.
Drug resistance caused by reversion mutation.
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »